BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32515734)

  • 21. Zinc-finger protein ZNF165 is a novel cancer-testis antigen capable of eliciting antibody response in hepatocellular carcinoma patients.
    Dong XY; Yang XA; Wang YD; Chen WF
    Br J Cancer; 2004 Oct; 91(8):1566-70. PubMed ID: 15354214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.
    Chen X; Cao X; Sun X; Lei R; Chen P; Zhao Y; Jiang Y; Yin J; Chen R; Ye D; Wang Q; Liu Z; Liu S; Cheng C; Mao J; Hou Y; Wang M; Siebenlist U; Eugene Chin Y; Wang Y; Cao L; Hu G; Zhang X
    Cell Death Dis; 2016 Dec; 7(12):e2508. PubMed ID: 27906182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.
    Risolino M; Mandia N; Iavarone F; Dardaei L; Longobardi E; Fernandez S; Talotta F; Bianchi F; Pisati F; Spaggiari L; Harter PN; Mittelbronn M; Schulte D; Incoronato M; Di Fiore PP; Blasi F; Verde P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3775-84. PubMed ID: 25157139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer.
    Majumder S; Bhowal A; Basu S; Mukherjee P; Chatterji U; Sengupta S
    J Cell Physiol; 2016 Nov; 231(11):2482-92. PubMed ID: 26919443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
    Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
    Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
    EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3.
    Naz S; Bashir M; Ranganathan P; Bodapati P; Santosh V; Kondaiah P
    Carcinogenesis; 2014 Jan; 35(1):14-23. PubMed ID: 23996929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-β/SMAD3 signaling pathway.
    Xu J; Ma L; Wang D; Yang J
    BMC Mol Cell Biol; 2022 Apr; 23(1):18. PubMed ID: 35413833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
    Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
    PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.
    Xue J; Lin X; Chiu WT; Chen YH; Yu G; Liu M; Feng XH; Sawaya R; Medema RH; Hung MC; Huang S
    J Clin Invest; 2014 Feb; 124(2):564-79. PubMed ID: 24382352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
    Petersen M; Pardali E; van der Horst G; Cheung H; van den Hoogen C; van der Pluijm G; Ten Dijke P
    Oncogene; 2010 Mar; 29(9):1351-61. PubMed ID: 20010874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells.
    Bae E; Sato M; Kim RJ; Kwak MK; Naka K; Gim J; Kadota M; Tang B; Flanders KC; Kim TA; Leem SH; Park T; Liu F; Wakefield LM; Kim SJ; Ooshima A
    Cancer Res; 2014 Nov; 74(21):6139-49. PubMed ID: 25205100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
    Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
    J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
    Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
    J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.
    Truong HH; Xiong J; Ghotra VP; Nirmala E; Haazen L; Le Dévédec SE; Balcioğlu HE; He S; Snaar-Jagalska BE; Vreugdenhil E; Meerman JH; van de Water B; Danen EH
    Sci Signal; 2014 Feb; 7(312):ra15. PubMed ID: 24518294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.
    Cherlet T; Murphy LC
    Mol Cell Biochem; 2007 Dec; 306(1-2):33-42. PubMed ID: 17660955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.